(Q37760087)

22 August 2017

1 reference

title

Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? (English)

1 reference

22 August 2017

1 reference

1 reference

3

Paolo Martelletti

1 reference

22 August 2017

Ivano Farinelli

1

1 reference

PubMed ID

20496013

22 August 2017

Ilaria Dionisi

series ordinal

2

1 reference

22 August 2017

22 May 2010

1 reference

Internal and emergency medicine

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

23-28

1 reference

22 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11739-010-0410-9

22 August 2017

0 references

cites work

Prevalence of frequent headache in a population sample

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Epidemiology of headache in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Kaplan Award 1998. Epidemiology of chronic daily headache in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Concepts and mechanisms of migraine chronification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Wind-up of spinal cord neurones and pain sensation: much ado about something?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Risk factors for headache chronification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Incidence and predictors for chronicity of headache in patients with episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Medication-overuse headache: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Management of medication-overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Prednisone as initial treatment of analgesic-induced daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Evidence for antinociceptive activity of botulinum toxin type A in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate inhibits trigeminovascular neurons in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Chronic migraine prevention with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate in the treatment of refractory chronic daily headache. An open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Time course of adverse events most commonly associated with topiramate for migraine prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Topiramate in migraine progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

A narrative review on the management of medication overuse headache: the steep road from experience to evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

21 January 2018

New drugs for migraine

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Future drugs for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

UPREGULATION OF SPINAL GLUTAMATE RECEPTORS IN CHRONIC PAIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-010-0410-9

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine

21 January 2018

1 reference

12 December 2020

Prednisone vs. placebo in withdrawal therapy following medication overuse headache.

1 reference

12 December 2020

Practical management of medication-overuse headache.

1 reference

12 December 2020

Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine

1 reference

12 December 2020

Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction

1 reference

12 December 2020

Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model

1 reference

12 December 2020

Medication overuse headache: rates and predictors for relapse in a 4-year prospective study

1 reference

12 December 2020

Pharmacogenomics in migraine: catching biomarkers for a predictable disease control [corrected]

1 reference

12 December 2020

10.1007/S11739-010-0410-9

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20496013